Frailty Syndrome and sarcopenia in older adults with and without type 2 diabetes mellitus in the municipality of Sinop, Mato Grosso: an epidemiological study.
Alan Nogueira da Cunha, Maria Lucia Zanetti, Jair Licio Ferreira Santos and 1 others
PMID 38055592WHAT IT FOUND
Older adults with type 2 diabetes were significantly more likely to be frail than those without diabetes.
Sarcopenia rates were similar in both groups. Physical inactivity strongly increased the likelihood of both frailty and sarcopenia.
Key findings
01Older adults with type 2 diabetes had a higher prevalence of frailty (67.1%) compared to those without diabetes (41.4%), a statistically significant difference.
02There was no significant difference in the prevalence of sarcopenia between older adults with type 2 diabetes (30.0%) and those without the disease (31.4%).
03Physical inactivity was associated with a thirteen times higher likelihood of developing frailty and a three times higher likelihood of developing sarcopenia.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPsWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The cross-sectional design prevents establishing causality between the identified risk factors and the development of frailty or sarcopenia. The sample size was limited to the total registration of eligible older adults in a single primary health unit, which may affect the generalizability of the findings to broader populations. The study did not assess the duration or severity of diabetes, which may influence the relationship between the disease and frailty.
Declared interests
The authors declared no conflicts of interest. The study was supported by the Federal University of Mato Grosso.
The easy way to misread this
Do not conclude that diabetes causes sarcopenia based on this paper. The study found no significant difference in sarcopenia rates between older adults with and without diabetes, despite the higher frailty rates in the diabetic group.